Exagen Inc. (XGN): Cost of Revenue
$27.78M
Year ended 2025-12-31
$29.42M
Trailing 12 months to 2026-06-30
+4.7%
3-year compound annual growth
+10.9%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $27.78M | +23.3% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $22.53M | -2.4% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $23.09M | -4.6% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $24.21M | +17.6% | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | $20.59M | +24.3% | 2023-03-20, From 2021-01-01 |
| 2020-12-31 | $16.56M | -12.0% | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | $18.81M | +22.3% | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | $15.38M | n/a | 2020-03-25, From 2018-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Exagen Inc. (XGN) | 2025-12-31 | $27.78M | +23.3% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $53.87M | -6.8% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $23.02M | +20.2% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $96.65M | +34.9% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $191.80M | +8.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $71.03M | +18.0% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $6.34M | -22.9% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $349.01M | +20.4% |
| YD Bio Ltd (YDES) | 2025-12-31 | $429.4K | +21.0% |
Compare XGN, PSNL, AMS, BLLN side by side · Screen every company in Services-Medical Laboratories ↗